Significance of A simple assay of urine telomerase activity for the detection of bladder cancer

Acta Urologica Japonica

Volumn 56, Issue 10, 2010, Pages 551-557

  Iwabuchi, Ikuya ^a   Mori, Kazuyuki ^a   Yamamoto, Hayato ^a   Hatakeyama, Shingo ^a   Yoneyama, Takahiro ^a   Hashimoto, Yasuhiro ^a   Koie, Takuya ^a   Kamimura, Noritaka ^a   Suzuki, Tadashi ^b   Ohyama, Chikara ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Aomori Hospital   (Japan)

Author keywords

Bladder cancer; Urine telomerase

Indexed keywords

TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 78649498402     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Badalament RA, Hemansen DK, Kimmel M, et al. : The sensitivity of bladder wash flowcytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 60 : 142-147, 1987
2. Sarosdy MF, Dcvere WRW, Soloway MS, et al.: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154: 374-384, 1995
3. D'Hallewin M and Baert L: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 155 : 475-476, 1996
4. Susan KK, Joseph VB, Gregory T, et al. : Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukar Gene Exp 3 : 189-241, 1996
5. Getzeberg RH, Konety BR, Oeler TA, et al. : Bladder cancer associated nuclear matrix proteins. Cancer Res 56: 1690-1694, 1996
6. Wiener HG, Haitel A, Pycha A, et al. : Can urine bound diagnosis tests replace cystoscopy in the management of bladder cancer ? J Urol 159 : 1876-1880, 1998
7. Serretta V, Lo PD, Vasile P, et al. : Urinary NMP22 for the detection of transitional cell carcinoma of the bladder: experience on 137 patients. Urology 52: 793-796, 1998
8. Miyanaga N, Akaza H, Tsukamoto T, et al. : Urinary nuclear matrix protein22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria. Int J Urol 6 : 173-177, 1999
9. Landman J, Chang Y, Kavaler E, et al. : Sensitivity and specificity of NMP22, telomerase, and BTA in the detection of human bladder cancer. Urology 52 : 398-402, 1998
10. Ishikawa F: Telomerase crisis, the driving force in cancer cell evolution. Biochem Biophys Res Commun 230 : 1-6, 1997
11. Wright WE, Piatyszek MA, Rainey WE, et al. : Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1996
12. Harley CB and Villeponteau B: Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5 : 249-255, 1995
13. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33 : 787-791, 1997
14. Lin Y, Miyamoto H, Fujinami K, et al.: Telomerase activity in human bladder cancer. Clin Cancer Res 2:929-932, 1996
15. Kinoshita H, Ogawa O, Kakehi Y, et al. : Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 89 : 724-730, 1997
16. Kim NW, Piatyzek MA, Prowse KR, et al. : Specific association of human telomerase activity with immortal cells and cancer. Science 266 : 2011-2015, 1994
17. Cheng AJ, Tang R, WangJY, et al. : Polymerase chain reaction-based enzyme immunoassay for quantitation of telomerase activity: application to colorectal cancers. Jpn J Cancer Res 90 : 280-285, 1999
18. BubenikJ, Baresova M, Viklicky V, et al. : Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer 11: 765-773, 1973
19. O'Toole C, Price ZH, Ohnuki Y, et al. : Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J cancer 38: 64-76, 1978
20. Bradford MM : A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
21. Kavaler E, Landman J, Chang Y, et al.: Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 82: 708-714, 1998
22. Ramakusmar S, Bhuiyan J, Besse AJ, et al. : Comparison of screening methods in the detection of bladder cancer. J Urol 161: 388-394, 1999
23. Droller MJ, Kavaler E, Landman J, et al. : Urinary telomerase and its possible role as a marker for bladder cancer. KeioJ Med 47: 135-141, 1998
24. Yoshida K, Sugino T, Tahara H, et al. : Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 79 : 362-369, 1997
25. Muller M, Heine B, Heicappell R, et al. : Telomerase activity in bladder cancer, bladder washings and in urine. Int J Oncol 9 : 1169-1173, 1996
26. Sharma S, Zippe CG, Pandrangi L, et al. : Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA STAT. J Urol 162 : 53-57, 1999
27. Eissa S, Swellam M, Ali-Labib R, et al. : Detection of telomerase in urine by 3 methods : evaluation of diagnostic accuracy for bladder cancer. J Urol 178 : 1068-1072, 2007
28. Bravaccini S, Casadio V, Amadori D, et al. : The current role of telomerase in the diagnosis of bladder cancer. Indian J Urol 25 : 40-46, 2009